Erratum: A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients (American Journal of Transplantation (2011) 11 (1927-1935) DOI: 10.1111/j.1600-6143.2011.03625.x);A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients

American Journal of Transplantation

Volumn 11, Issue 9, 2011, Pages 1927-1935

  Kim, S H ^a   Lee, S O ^a   Park, J B ^a   Park, I A ^a   Park, S J ^a   Yun, S C ^a   Jung, J H ^a   Kim, Y H ^a   Kim, S C ^a   Choi, S H ^a   Jeong, J Y ^a   Kim, Y S ^a   Woo, J H ^a   Park, S K ^a   Park, J S ^a   Han, D J ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

ELISPOT assay; kidney transplantation; tuberculosis

Indexed keywords

ISONIAZID;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT; LATENT TUBERCULOSIS; LIVER FUNCTION TEST; LIVER TOXICITY; LIVING DONOR; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; SINGLE BLIND PROCEDURE; T LYMPHOCYTE; TUBERCULIN TEST;

EID: 80052262326     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03832.x     Document Type: Erratum

References (35)

1. Wallis RS, Pai M, Menzies D, Walzl G, Perkins MD, Zumla A,. Biomarkers and diagnostics for tuberculosis: Progress, needs, and translation into practice. Lancet 2010; 375: 1920-1937.
2. Lalvani A, Pareek M,. A 100 year update on diagnosis of tuberculosis infection. Brit Med Bull 2010; 93: 69-84.
3. Pai M, Riley LW, Colford JM,. Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis 2004; 4: 761-766. (Pubitemid 39574348)
4. Lalvani A, Pathan AA, Durkan H, et al., Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357: 2017-2021. (Pubitemid 32592390)
5. Ewer K, Deeks J, Alvarez L, et al., Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173. (Pubitemid 36398385)
6. Kim SH, Song KH, Choi SJ, et al., Diagnostic Usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009; 122: 189-195.
7. Kim SH, Cho OH, Park SJ, et al., Diagnosis of abdominal tuberculosis by T-cell-based assays on peripheral blood and peritoneal fluid mononuclear cells. J Infect 2009; 59: 409-415.
8. Kim SH, Cho OH, Park SJ, et al., Rapid diagnosis of tuberculous meningitis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Infect Dis 2010; 50: 1349-1358.
9. Cho OH, Park SJ, Park KH, et al., Diagnostic usefulness of a T-cell-based assay for osteoarticular tuberculosis. J Infect 2010; 61: 228-234.
10. Kim SH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW,. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis. Arch Intern Med 2007; 167: 2255-2259.
11. Watkins RE, Brennan R, Plant AJ,. Tuberculin reactivity and the risk of tuberculosis: A review. Int J Tuberc Lung Dis 2000; 4: 895-903.
12. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A,. Negative and positive predictive value of a whole blood interferon-γ releasing assay for developing active tuberculosis: An update. Am J Respir Crit Care Med 2011; 183: 88-95.
13. Bakir M, Millington KA, Soysal A, et al., Prognostic value of a T-cell-based, interferon- γ biomarker in children with tuberculosis contact. Ann Intern Med 2008; 149: 777-786.
14. Hill PC, Jackson-Sillah DJ, Fox A, et al., Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 2008; 3: e1379.
15. Aichelburg MC, Rieger A, Breitenecker F, et al., Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954-962.
16. Singh N, Paterson DL,. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998; 27: 1266-1277. (Pubitemid 29242482)
17. Torre-Cisneros J, Doblas A, Aguado JM, et al., Tuberculosis after solid-organ transplant: Incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48: 1657-1665.
18. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant 2004; 4 (Suppl 10): 164-166.
19. Muñoz P, Rodríguez C, Bouza E,. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40: 581-587. (Pubitemid 40270229)
20. World Health Organization. Available at: [accessed 28 February 2011]
21. Park SB, Suk J, Joo I, et al., Tuberculosis complicating kidney transplantation. J Korean Soc Transplant 1995; 9: 95-102 [Korean.
22. Kim SH, Lee SO, Park IA, et al., Diagnostic usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transpl Infect Dis 2010; 12: 113-119.
23. Korea Centers for Diseases Control and Prevention. TB control guideline 2010. (Accessed July 14, 2010, at.)
24. Moreno S, Baraia-Etxaburu J, Bouza E, et al., Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194-198. (Pubitemid 23327618)
25. Kik SV, Franken WP, Mensen M, et al., Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010; 35: 1346-1353.
26. Leyten EM, Arend SM, Prins C, et al., Discrepancy between Mycobacterium tuberculosis-specific gamma interferon releasing assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 2007; 14: 880-885.
27. Jonnalagadda S, Lohman Payne B, Brown E, et al., Latent tuberculosis detection by interferon γ releasing assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis 2010; 202: 1826-1835.
28. Leung CC, Yam WC, Yew WW, et al., T-SPOT.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med 2010; 182: 834-840.
29. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161(Pt 2): S221-S247.
30. Aguado JM, Herrero JA, Gavaldá J, et al., Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation 1997; 63: 1278-1286. (Pubitemid 27212823)
31. Passalent L, Khan K, Richardson R, et al., Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007; 2: 68-73.
32. Triverio PA, Bridevaux PO, Roux-Lombard P, et al., Interferon-gamma releasing assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dialysis Transplant 2009; 24: 2186-2189.
33. Smith KC, Orme IA, Starke JR,. Tuberculosis vaccines. In:, Plotkin S, Orenstein W, Offit P, eds. Vaccines. Philadelphia, PA: Saunders/Elsevier 2007: 857-885.
34. Meier-Kriesche HU, Port FK, Ojo AO, et al., Effect of waiting time on renal transplant outcome. Kindey Int 2000; 58: 1311-1317.
35. Hernandez-Hernandez E, Alberã J, González-Michaca L, et al., Screening for tuberculosis in the study of the living renal donor in a developing country. Transplantation 2006; 81: 290-292.